Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Radiat Oncol. 2021 Dec 2;16(1):230. doi: 10.1186/s13014-021-01941-z.
No abstract available

Publication types

  • Published Erratum